Forbes Pharmaceuticals Private Limited

Forbes Pharmaceuticals Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U51397MH2009PTC194676 Incorporated 05 August 2009 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company pharma
Data last updated
Authorised capital
₹25 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
17 yrs
Est. 2009
Directors on board
2
As per MCA filings
Brands
1
Associated brands
Last financials
Mar 2025
Balance sheet date
Last AGM
30 Sep 2025
Annual general meeting
Company status
Active
MCA master data

About Forbes Pharmaceuticals Private Limited

Data last updated:

Forbes Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 05 August 2009 and has been in existence for over 17 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51397MH2009PTC194676.

The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Atul Chimanlal Kamdar (Managing Director) and Jagruti Atul Kamdar.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A/1102 Krushal Tower M.G. Rd. Amar Mahal Tilaknagar Chembur, Mumbai, Maharashtra, India – 400089.

The company is associated with 1 brand: Forbes Pharmaceuticals. Court records list 3 cases involving the company, including 1 filed by the company and 2 filed against it.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website metalicchem.com.

Company details

CIN U51397MH2009PTC194676
Registration Number 194676
Incorporation Date 05 August 2009
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

Contact details

Forbes Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its website is metalicchem.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    A/1102 Krushal Tower M.G. Rd. Amar Mahal Tilaknagar Chembur, Mumbai, Maharashtra, India – 400089
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Forbes Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Forbes Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Forbes Pharmaceuticals operates one associated brand: Forbes Pharmaceuticals. Each brand links to its own profile.

BrandDescriptionWebsite
Manufactures and exports specialty chemicals and compounds for food, textile, and pharmaceutical sectors.metalicchem.com

Financials of Forbes Pharmaceuticals Private Limited

FY 2025 filings available

Financial Statement Summary

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA
Profit Before Tax
Tax Expense
Net Profit (PAT)
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profitability
EBITDA Margin
Net Profit Margin
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Forbes Pharmaceuticals Private Limited, buy the company report.

Board of directors of Forbes Pharmaceuticals Private Limited

Forbes Pharmaceuticals has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Atul Chimanlal KamdarManaging Director05 Aug 200917 Years 2 MonthsCurrent
Jagruti Atul KamdarDirector05 Aug 200917 Years 2 MonthsCurrent

Auditor

Forbes Pharmaceuticals Private Limited is audited by SURENDRA PARIKH & CO for the financial year 2023.

Auditor firmFinancial yearFirm registration number
SURENDRA PARIKH & COFY 2023035906

Shareholding

The shareholding of Forbes Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Forbes Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Forbes Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Forbes Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Forbes Pharmaceuticals Private Limited has 2 board changes on record since 2009: 2 appointments. The latest: Atul Chimanlal Kamdar was appointed as Managing Director on 05 Aug 2009.

AGM
Forbes Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Forbes Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Appointed
Atul Chimanlal Kamdar was appointed as Managing Director.
Appointed
Jagruti Atul Kamdar was appointed as Director.
Incorporation
05 Aug 2009
Forbes Pharmaceuticals Private Limited was registered on 05 Aug 2009 with Roc Mumbai & aged 17 years 2 months as per MCA records.

Frequently asked questions

Forbes Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 05 August 2009 (17+ years old) and is registered under CIN U51397MH2009PTC194676.

Forbes Pharmaceuticals has 2 current directors:

The latest financial statements of Forbes Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The CIN (Corporate Identification Number) of Forbes Pharmaceuticals is U51397MH2009PTC194676. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Forbes Pharmaceuticals has 3 court cases on record: 1 filed by the company and 2 filed against it.

Forbes Pharmaceuticals was incorporated on 05 August 2009, making it 17+ years old. It is registered with the Registrar of Companies, Mumbai.

Atul Chimanlal Kamdar was appointed as Managing Director on 05 Aug 2009. Jagruti Atul Kamdar was appointed as Director on 05 Aug 2009.

Forbes Pharmaceuticals can be reached through the website metalicchem.com. Its registered office is in Mumbai, Maharashtra, India.

The registered office of Forbes Pharmaceuticals is at A1102 Krushal Tower M.G. Rd. Amar Mahal Tilaknagar Chembur, Mumbai, Maharashtra, India – 400089.

Forbes Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.